Improved Annual Contract Value
Annual contract value improved to 1.6%, with a 30 basis point sequential improvement, driven by 2% ACV growth in Academia & Government and Life Sciences & Health.
Strong Renewal Rates
Renewal rate increased by 100 basis points year-over-year to 93%.
Significant Debt Reduction and Share Repurchase
Clarivate paid down $100 million in debt and repurchased $115 million in shares year-to-date.
AI and Product Innovation
Launched 12 new products and AI-powered capabilities, enhancing product offerings across all segments.
Positive Revenue Performance
Quarterly revenue was $623 million, bringing year-to-date revenue to $1.84 billion, with a strong showing in the Life Science and Health segment.